Back

Anticoagulation for cancer-associated venous thromboembolism: navigating between risks of recurrence and bleeding

European Heart Journal

5 September 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS

Contributors

Sabine Eichinger
Sabine Eichinger

Author

Paul A Kyrle
Paul A Kyrle

Author

You may be interested in
thumbnail
Webinar
Anticoagulation issues in cancer patients
26 April 2021
thumbnail
Congress Presentation
Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism
3 September 2019
thumbnail
Congress Presentation
Risk factors of recurrence in patients with cancer-associated venous thromboembolism: from the COMMAND VTE Registry
28 August 2021
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources